$600 billion
Estimated global market opportunity for menopause-related products and services by 2030.
10.80%
Percentage of the NIH 2020 budget allocated to women's health research, including female-specific and predominant conditions.
1%
Percentage of global healthcare R&D investments that target female-specific conditions beyond oncology.
Women drive 80% of healthcare decisions and fuel the $500B U.S. healthcare and beauty market, yet women’s R&D is a blind spot in the biotech field - it is underpriced and a massive opportunity.
Additional Documentation
Summary
While science drives breakthroughs like extended lifespans and everyday technologies, women’s health R&D is a black box. We know very little about female biology, yet we depend on it for the human population.
Problem
While science drives breakthroughs like extended lifespans and everyday technologies, women’s health R&D is a black box. We know very little about female biology, yet we depend on it for the human population.
Impact
While science drives breakthroughs like extended lifespans and everyday technologies, women’s health R&D is a black box. We know very little about female biology, yet we depend on it for the human population.
Summary
＠athena_DAO_ on 𝕏
Discord community
cdn.prod.website-files.com
AthenaDAO Whitepaper
naomiii.medium.com
How Athena DAO is funding the underfunded: Women’s Health Research
femtechworld.co.uk
